Il Gruppo Ulisse Biomed è un gruppo biotech integrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.
Il Gruppo Ulisse Biomed è un gruppo biotech intyegrato con tecnologie proprietarie, che sviluppa soluzioni diagnostiche, con un focus su salute pubblica, diagnostica distribuita e innovazione molecolare.
Ulisse Biomed è pienamente impegnata a sostenere i settori healthcare and medicali.
Ulisse Biomed fornisce una gamma completa di soluzioni diagnostiche diverse, con l'obiettivo di valutare in tempo reale molte minacce per la salute umana e di ridurre al minimo i rischi legati alla diffusione di agenti patogeni e alle conseguenti infezioni attraverso specifici protocolli di monitoraggio delle infezioni.
Determination of POLYMORPHISM -455 G>A OF FGB GENE (fibrinogen)
T1565C GPIIIa POLYMORPHISM (ITGB3 gene)
Determination of T1565C GPIIIa POLYMORPHISM (ITGB3 gene)
Cardiovascolare
Name
Description
AGT gene T9543C POLYMORPHISM
Determination of AGT gene T9543C POLYMORPHISM
T3932C POLYMORPHISM (CYS112ARG) APO-E
Determination of T3932C POLYMORPHISM (CYS112ARG) APO-E
C4070T POLYMORPHISM (ARG158CYS) APO-E
Determination of C4070T POLYMORPHISM (ARG158CYS) APO-E
R3500Q MUTATION (R3527Q) APO B-100
Determination of R3500Q MUTATION (R3527Q) APO B-100
POLYMORPHISM A1166C AGTR1
Determination of POLYMORPHISM A1166C AGTR1
MTRR A66G POLYMORPHISM
Determination of MTRR A66G POLYMORPHISM
Emocromatosi
Name
Description
HFE GENE C282Y MUTATION
Determination of HFE GENE C282Y MUTATION
H63D HFE gene MUTATION
Determination of H63D HFE gene MUTATION
HFE gene S65C MUTATION
Determination of HFE gene S65C MUTATION
R3500Q MUTATION (R3527Q) APO B-100
Determination of R3500Q MUTATION (R3527Q) APO B-100
POLYMORPHISM A1166C AGTR1
Determination of POLYMORPHISM A1166C AGTR1
MTRR A66G POLYMORPHISM
Determination of MTRR A66G POLYMORPHISM
Risposta immunitaria
Name
Description
C/T polymorphism of CCR3 gene
Determination of C/T polymorphism of CCR3 gene
POLYMORPHISM G/A gene cluster IL18RAP
Determination of POLYMORPHISM G/A gene cluster IL18RAP
Oncologia
Name
Description
POLYMORPHISM -397 T>C ESR1 (dbSNP ID: rs2234693)
Determination of POLYMORPHISM -397 T>C ESR1 (dbSNP ID: rs2234693)
POLYMORPHISM *39 AG ESR2 A1730G (dbSNP ID:rs4986938)
Determination of POLYMORPHISM *39 AG ESR2 A1730G (dbSNP ID:rs4986938)
03
Oncoematologia
Sindromi mieloproliferative
Name
Description
JAK2 (Janus kinase 2)
Qualitative and quantitative determination of the V617F mutation of the JAK2 gene(Janus kinase 2)
MPL
Determination of W515L/K mutations in the MPL gene(Mieloproliferative Leukemia Virus Oncogene)
CALR (chaperone calreticulin)
Qualitative determination of INS 5bp/DEL 52bp mutations of exon 9 of the CALR gene(chaperone calreticulin)
Lecuemia acute e cronica
Name
Description
BCR-ABL1 t(9;22)
Qualitative determination of the translocation t(9; 22) of BCR-ABL1 and identification of p190 transcripts; p210 and p230 of the endogenous abl gene (Sample Eligibility)
PML-RARA t(15;17) (q22;q21)
Qualitative determination of the translocation t(15; 17) PML-RARA t(9; 22) and identification of the BCR1, BRC2 and BCR3 transcripts of the endogenous ABL gene
AML1-ETO t(8;21) (Q22;Q22)
Qualitative determination of the translocation t(8; 21) AML-ETO and the endogenous gene abl
CBFB-MYH11 INV (16) (p13q22)
Qualitative detection of pericentric inversion INV 16, CBFB-MYH11 and identification of transcripts A, D and E
Oncologia
Name
Description
BRAF V600E (T1799A) mutation
Qualitative detection of V600E mutation of the BRAF gene
04
Farmacogenetica
Metabolismo e tossicità dei farmaci
Name
Description
VARIANTS OF DPYD (DPYD *2A, *13, Asp949Val, 1236 G>A, HapB3 and 2194 G>A, *6)
Detection of genetic variants *2A (rs3918290, 1905 +1G>A, IVS14 +1 G>A), *13 (rs55886062, 1679 T>G), Asp949Val, (rs67376798, 2846 A>T), 1236 G>A (rs 56038477, HapB3) and *6 (2194 G>A, rs 1801160) of the gene DPYD
VARIANTS OF UGT1A1*1 AND UGT1A1*28
Characterization of the genetic variants UGT1A1*1 and UGT1A1*28 of the UGT gene
GSTP1 GENE VARIANT A313G (I105V)
Characterization of the A313G genetic variant of the GSTP1 gene (rs1695)
VARIANTS OF CYTOCHROME P450 CYP2C9 (variants *2 and *3)
Detection of the genetic variants rs1799853 (*2) and rs1057910 (*3) of the CYP2C9 gene
VARIANTS 197 G>T and 19007 T>C OF THE ERCC1 GENE
Determination of the genetic variants 197 G>T (rs3212986) and 19007 T>C (Asn118Asn; NM_001369414.1: c.354T>C, rs11615) of the ERCC1 gene
Screening farmacogenetico
Name
Description
ABCB1 (MDR1) GENE VARIANT G2677T/A
Detection of genetic variant G2677T; G>T / G2677A; G>A) of the gene ABCB1 (rs2032582)
ABCB1 (MDR1) GENE VARIANT C3435T
Characterization of the C3435T genetic variant of the ABCB1 gene (rs1045642)
ABCB1 (MDR1) GENE VARIANT C1236T
Characterization of the genetic variant C1236T of the ABCB1 gene (rs1128503)
VARIANT ARG399GLN OF THE XRCC1 GENE
Determination of the ARG399GLN polymorphism of the XRCC1 gene (G>A; ARG399GLN; rs25487)
MGMT gene promoter methylation (O6-methylguanine DNA methyltransferase)
Determination of the methylation status of the MGMT (O6-methylguanine DNA methyltransferase) gene promoter by MSP
Impact of Full Vaccination with mRNA BNT162b2 on SARS-CoV-2 Infection: Genomic and Subgenomic Viral RNAs Detection in Nasopharyngeal Swab and Saliva of Health Care Workers
